← Back to headlines
Alkermes Expects Q3 2026 Revenues of $450M-$470M Amid CEO Transition
Alkermes anticipates total revenues between $450 million and $470 million for Q3 2026. This outlook comes as the company approaches a CEO transition and awaits readouts from its orexin programs.
28 Jul, 19:04 — 28 Jul, 19:04
Sources
Showing 1 of 1 sources
